DUSA Pharmaceuticals to be Acquired by Sun Pharmaceutical, Investigations Start (DUSA)

DUSA Pharmaceuticals (NASDAQ: DUSA) will be investigated by Block & Leviton LLP for possible breaches of fiduciary duties by the Board of Directors in relation to the proposed acquisition by Sun Pharmaceutical Industries in a cash transaction of around $8.00 per share. The terms of the acquisition were announced on November 8, 2012. This places […]